Alector, Inc. (ALEC)
2.155
+0.04
(+2.13%)
USD |
NASDAQ |
Mar 04, 16:00
2.155
0.00 (0.00%)
After-Hours: 20:00
Alector Research and Development Expense (Annual) : 113.40M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Vistagen Therapeutics, Inc. | 39.38M |
| Ocugen, Inc. | 30.16M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |
| Savara, Inc. | 78.03M |